Click here to view the Providence Health Plan Medical Policy Updates » September 2024 Providence…
Aetna Medical Policy Updates – May 2019
Click here to view the Aetna Medical Policy Updates »
May 2019 Aetna Medical Policy Updates:
- Atezolizumab (Tecentriq)
- Autologous Chondrocyte Implantation
- Back Pain – Non Invasive Treatments
- Breast Reconstructive Surgery
- Bupivacaine Liposome (Exparel) – Medical Clinical Policy Bulletins | Aetna
- Burosumab-twza (Crysvita) – Medical Clinical Policy Bulletins | Aetna
- Caplacizumab-yhdp (Cablivi) – Medical Clinical Policy Bulletins | Aetna
- Capsule Endoscopy
- Cardiac Contractility Modulation (CCM) Therapy – Medical Clinical Policy Bulletins | Aetna
- Cardiac CT, Coronary CT Angiography and Calcium Scoring
- Cemiplimab (Libtayo) – Medical Clinical Policy Bulletins | Aetna
- Chelation Therapy
- Chiari Malformation Decompression Surgery – Medical Clinical Policy Bulletins | Aetna
- Chronic Vertigo
- Comparative Genomic Hybridization (CGH)
- Dermabrasion, Chemical Peels, and Acne Surgery
- Dorsal Column Stimulation
- Electroretinography
- Emapalumab-lzsg (Gamifant) – Medical Clinical Policy Bulletins | Aetna
- Epidural Patching – Medical Clinical Policy Bulletins | Aetna
- Erythropoiesis Stimulating Agents
- Evoked Potential Studies
- External Counterpulsation (ECP)
- Extracorporeal Photochemotherapy (Photopheresis)
- Fetal Fibronectin, Inflammatory Biomarkers, and Salivary Estriol Testing for Preterm Labor
- Fiberoptic Endoscopic Evaluation of Swallowing (FEES)/Fiberoptic Endoscopic Evaluation of Swallowing with Sensory Testing (FEESST)
- Gastroesophageal Reflux Disease (GERD): Treatment Devices
- Growth Hormone (GH) and Growth Hormone Antagonists
- Hepatitis A Vaccine
- Hereditary Transthyretin-Mediated (hATTR) Amyloidosis – Medical Clinical Policy Bulletins | Aetna
- Hippotherapy
- Hospitalization for the Initiation of Ketogenic Diet for the Treatment of Intractable Seizures
- Hyperbaric Oxygen Therapy (HBOT)
- Ibalizumab-uiyk (Trogarzo) – Medical Clinical Policy Bulletins | Aetna
- Inflammatory Bowel Disease: Serologic Markers and Pharmacogenomic and Metabolic Assessment of Thiopurine Therapy
- Infusion Pumps
- Iontophoresis
- Ketamine for the Treatment of Depression – Medical Clinical Policy Bulletins | Aetna
- Lutetium Lu 177 Dotatate (Lutathera) – Medical Clinical Policy Bulletins | Aetna
- Lyme Disease and other Tick-Borne Diseases
- Lysosomal Storage Disorders Treatments
- Magnetic Resonance Imaging (MRI) of the Extremities
- Magnetic Resonance Spectroscopy (MRS)
- Mifepristone (RU 486)
- Mogamulizumab-kpkc (Poteligeo) – Medical Clinical Policy Bulletins | Aetna
- Mometasone Furoate Sinus Implant (Sinuva) – Medical Clinical Policy Bulletins | Aetna
- Moxetumomab Pasudotox-tdfk (Lumoxiti) – Medical Clinical Policy Bulletins | Aetna
- Obesity Surgery
- Olaratumab (Lartruvo)
- Oprelvekin (Neumega)
- Panitumumab (Vectibix)
- Parenteral Immunoglobulins
- Pegvaliase-pqpz (Palynziq) – Medical Clinical Policy Bulletins | Aetna
- Phonophoresis
- Plantar Fasciitis Treatments
- Polymerase Chain Reaction Testing: Selected Indications
- Progestins
- Prolotherapy
- Prostate Cancer Screening
- Pulmonary Hypertension Treatments and Selected Indications of Prostanoids
- Quantitative EEG (Brain Mapping)
- Ravulizumab-cwvz (Ultomiris) – Medical Clinical Policy Bulletins | Aetna
- Ribavirin (Virazole)
- Sinus Surgeries – Medical Clinical Policy Bulletins | Aetna
- Speech Therapy
- Spinal Surgery: Laminectomy and Fusion
- Sufentanil Sublingual Tablet (Dsuvia) – Medical Clinical Policy Bulletins | Aetna
- Tagraxofusp-erzs (Elzonris) – Medical Clinical Policy Bulletins | Aetna
- Total Body Photography and Dermoscopy
- Transjugular Intrahepatic Portosystemic Shunt (TIPSS)
- Transmyocardial and Endovascular Laser Revascularization
- Trastuzumab (Herceptin), Ado-Trastuzumab (Kadcyla) and Pertuzumab (Perjeta)
- Tumor Scintigraphy
- Urinary Incontinence
- Vagus Nerve Stimulation
- Varicella and Herpes Zoster Vaccines
- Viscosupplementation
- Vitamin D Assay – Medical Clinical Policy Bulletins | Aetna
- Xolair (Omalizumab)
Click here to view the Aetna Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
